Tenax Therapeutics to Present at the 36th Annual Roth ConferenceGlobe Newswire • 3 months agoCHAPEL HILL, N.C., March 12, 2024 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX), a Phase 3, development-stage pharmaceutical company focused on identifying, developing and...